Abingdon Health develops, manufactures and markets innovative medical diagnostics for clinics and laboratories worldwide to enable rapid, accurate, and low-cost diagnosis.
Our initial development focus is in the field of haematology oncology and specifically in the area of B-Cell dyscrasias. Our first rapid testing product in this market is Seralite® – FLC, the world’s first rapid device for aiding the diagnosis and monitoring of multiple myeloma patients.
We also supply nucleic acid lateral flow immunoassays and antibodies. Learn more: www.abingdonhealth.com/other-products
Seralite® – FLC Serum
Rapid test for the quantitative measurement of free light chains (FLCs) in diagnosis and monitoring of multiple myeloma.Read More
Nucleic acid lateral flow immunoassays
Abingdon Health manufactures nucleic acid lateral flow immunoassays (NALFIA), called PCRD and PCRD FLEX,Read More
Several #job vacancies: ✅R&D Scientist ✅Technical Transfer Scientist ✅Quality Control Supervisor ✅Quality Control… https://t.co/KgK0XS6Hdf
21 March 2019
© Abingdon Health 2019